NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH)
Post# of 12
(Total Views: 250)
Posted On: 03/08/2022 3:51:53 PM
NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device
RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number 107475 allows RYAH to market its Smart Medical Inhaler System to medical patients in Canada and potentially represents a significant boost to RYAH’s growth strategy. “The approval from Health Canada recognizing the RYAH Smart Inhaler System as a medical device is a major step towards achieving our global medical device footprint,” said the company’s CEO Gregory Wagner. “Once again, certification for both our software and hardware puts us in a unique position to provide objective data analytics, which is critical for developing highly personalized cannabis therapies. We expect the Health Canada MDL will aid RYAH’s efforts to obtain additional country specific-certifications, including New Zealand, Australia and beyond.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number 107475 allows RYAH to market its Smart Medical Inhaler System to medical patients in Canada and potentially represents a significant boost to RYAH’s growth strategy. “The approval from Health Canada recognizing the RYAH Smart Inhaler System as a medical device is a major step towards achieving our global medical device footprint,” said the company’s CEO Gregory Wagner. “Once again, certification for both our software and hardware puts us in a unique position to provide objective data analytics, which is critical for developing highly personalized cannabis therapies. We expect the Health Canada MDL will aid RYAH’s efforts to obtain additional country specific-certifications, including New Zealand, Australia and beyond.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)